Mikio Momoeda

No ORCID on file · 33 papers in corpus · active 1997-2024

Study types

  • article 25
  • other 6
  • letter 1
  • review 1

Condition tags

  • endometriosis 26
  • mesh:D004715 20
  • dysmenorrhea 12
  • infertility 6
  • mesh:D004412 5
  • mesh:D017699 5
  • dyspareunia 4
  • adenomyosis 4
  • mesh:D004414 3
  • chronic_pelvic_pain 3
article 2024
Reproductive health ·doi:10.1186/s12978-024-01739-8

BACKGROUND: Endometriosis-related pain encompassing dysmenorrhea, dyspareunia, and chronic pelvic pain, reduces the quality of life in premenopausal women. Although treatment options for endometriosis alleviate this pain, approximately one-…

article 2023
·doi:10.1186/s12905-023-02652-1

BACKGROUND: The purpose of this study was to establish an estimating equation to predict the 5-level EQ-5D version (EQ-5D-5L) utility score in patients taking iron preparations for heavy menstrual bleeding (HMB) or anemia and to evaluate wh…

article 2022
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625187.2022.2067329

PURPOSE: To collect real-world safety and clinical outcome data on the levonorgestrel-releasing intrauterine system (LNG-IUS) for functional/organic heavy menstrual bleeding (HMB) and dysmenorrhoea in Japanese women (J-MIRAI). MATERIALS AND…

article 2022
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.15416

More than 10 years following the publication of "The General Rules for Clinical Management of Endometriosis: The second edition" in January 2010, the long-awaited third edition has arrived. The second edition represents the bible for endome…

article 2022
Contraception ·doi:10.1016/j.contraception.2022.08.006

ObjectivesWe collected real-world data on the safety and clinical outcomes of the levonorgestrel-releasing intrauterine system (LNG-IUS) for heavy menstrual bleeding and dysmenorrhea.Study DesignThis was a prospective, multicenter, single-c…

article 2021
Reproductive medicine and biology ·doi:10.1002/rmb2.12391

PURPOSE: To assess the efficacy and safety of dydrogesterone in Japanese women with ovarian endometrioma in a real-world setting. METHODS: The post-marketing study involved 15 sites in Japan. Dydrogesterone 10 mg twice daily orally was admi…

other 2018
Cost effectiveness and resource allocation : C/E ·doi:10.1186/s12962-018-0097-8

BACKGROUND AND OBJECTIVE: This study aims to assess the cost-effectiveness of early physician consultation and guideline-based intervention to prevent endometriosis and/or disease progression using oral contraceptive (OC) and progestin comp…

article 2017
Fertility and sterility ·doi:10.1016/j.fertnstert.2017.07.1165

ObjectiveTo investigate the efficacy and safety of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen (FlexibleMIB) compared with placebo to treat endometriosis-associated pelvic pain (EAPP).DesignA phase 3, randomized,…

article 2016
·doi:10.1016/j.fertnstert.2016.08.051
article 2015
·doi:10.1016/j.jval.2015.09.2824
article 2014
Gynecologic and obstetric investigation ·doi:10.1159/000357819

OBJECTIVE: To investigate the clinical features of patients in Japan with malignant transformation of ovarian endometrioma. PATIENTS: Thirty-three patients diagnosed with ovarian cancer presumably arising from endometrioma were recruited re…

other 2014
International journal of women's health ·doi:10.2147/IJWH.S70935

BACKGROUND: The purpose of this study was to investigate the effectiveness of a combination of ethinylestradiol (EE) and 0.02 mg/drospirenone (DRSP) 3 mg in Japanese women with dysmenorrhea and in particular to determine whether or not the …

other 2013
International journal of women's health ·doi:10.2147/IJWH.S52429

BACKGROUND: Menstrual symptoms are associated with various health problems in women of reproductive age, and this may impact their quality of life. Despite this, Japanese women are likely to hesitate seeking a specialist's medical help for …

article 2011
·doi:10.5180/jsgoe.27.296

Objective: The efficacy of diagnostic laparoscopy should be re-considered due to the improved success rate of assisted reproductive technologies (ART). Methods: We retrospectively reviewed clinical records of 126 women who were examined by …

other 2009
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/j.1447-0756.2009.01076.x

AIM: To investigate the safety and efficacy of 52 weeks of dienogest treatment in patients with endometriosis. METHODS: One hundred and thirty-five patients with endometriosis received 2 mg of dienogest orally each day for 52 weeks. Advers…

article 2008
Fertility and sterility ·doi:10.1016/j.fertnstert.2007.12.080
article 2008
Fertility and sterility ·doi:10.1016/j.fertnstert.2007.08.051
article 2007
Reproductive medicine and biology ·doi:10.1111/j.1447-0578.2007.00163.x

Aim: Hysterosalpingography (HSG) is one of the most commonly used methods in order to evaluate the condition of fallopian tubes in infertility clinics. In the present paper, we retrospectively compared the findings of HSG and laparoscopy to…

other 2007
Reproductive medicine and biology ·doi:10.1111/j.1447-0578.2007.00189.x

Aim:  Dienogest, a novel progestational 19-norsteroid, has been shown to have a therapeutic effect on endometriosis with its major side-effect being irregular genital bleeding. This study aimed to investigate the mechanism responsible for t…

article 2004
Human Reproduction ·doi:10.1093/humrep/deh412

BACKGROUND: Failure of apoptosis of refluxed endometrial cells within the peritoneal cavity is a possible etiologic factor for development of endometriosis. Osteoprotegerin (OPG) is a survival factor that exerts its effect by binding to tum…

other 2003
Human Reproduction ·doi:10.1093/humrep/deg243

BACKGROUND: To evaluate the usefulness of transvaginal and transrectal ultrasonography for diagnosis and management of deeply infiltrating rectosigmoid endometriosis. METHODS: A series of six patients (aged 32-39 years) with rectosigmoid e…

article 2003
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1034/j.1600-0897.2003.00037.x

PROBLEM: To assess whether interferon-gamma-induced protein-10 (IP-10), a chemokine that has antiangiogenic activities, may be involved in the pathogenesis of endometriosis. METHOD OF STUDY: A total of 120 patients undergoing laparoscopy fo…

article 2002
Gynecologic and obstetric investigation ·doi:10.1159/000066290

To address the contrasting findings regarding how pain is related to endometriosis, the relationship between pain and stage of endometriosis was dissected differently by the chief complaint to eliminate selection biases. A total of 1,092 wo…

review 2002
Gynecologic and obstetric investigation ·doi:10.1159/000049422

Endometriosis is assumed to be one of the causative factors of infertility, although the mechanism remains to be elucidated. Mechanical factors distorting the pelvic anatomy and/or changes in the biochemical and cellular environment in the …

article 2001
Nihon rinsho. Japanese journal of clinical medicine